This includes the glycogen debranching enzyme AGL which had a suppressing function in models of bladder and lung cancers, and the kinase PhK β-subunit (PHKB) which suppressed models of hepatocellular carcinoma (18–21). The gene discussed is AGL; the disease is hepatocellular carcinoma.